Cancer Medicines To Get Cheaper? Govt Caps Margins At 30% For Non-Scheduled Drugs
The government has expanded price controls on non-scheduled cancer medicines by capping margins at 30% of the maximum retail price (MRP).
The government has expanded price controls on non-scheduled cancer medicines by capping margins at 30% of the maximum retail price (MRP).
